Parker Bioscience’s UK site to see multi-million dollar investment through 2018

By Melissa Fassbender

- Last updated on GMT

Getty/Norasit Kaewsai
Getty/Norasit Kaewsai
Parker Bioscience’s UK-based site will be expanded as part of a multi-million dollar phased investment program to be completed throughout 2018.

Parker Hannifin has announced a major investment in its Parker Bioscience division, which supplies and delivers systems for upstream and downstream pharmaceutical and biopharmaceutical manufacturing. The division has sites in Birtley, UK and Oxnard, CA in the US.

The investment will expand Parker Bioscience’s laboratory, clean room, office and warehouse facilities. According to the company, it also will make the division’s Birtley premises “one of the most modern manufacturing sites for integrated bioprocessing solutions in EMEA.”

Mike Brailsford, General Manager at Parker Bioscience, said: “The increased capacity will help us to offer larger scale services to biopharmaceutical manufacturers in Europe and across the globe, and is a major milestone in the division’s growth.”

Parker Bioscience has not responded to a request for comment.

Related news

Related products

show more

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Related suppliers

Follow us


View more